Cytokinetics Inc
(NAS:CYTK)
$
59.23
-0.91 (-1.51%)
Market Cap: 6.21 Bil
Enterprise Value: 6.44 Bil
PE Ratio: 0
PB Ratio: 0
GF Score: 41/100 Cytokinetics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 10, 2020 / 08:40PM GMT
Release Date Price:
$21.71
(+3.14%)
Graig Suvannavejh
Goldman Sachs Group Inc., Research Division - Executive Director & Senior Equity Research Analyst
Well, good afternoon, everyone. Welcome to the 4:40 p.m. session here at day 2 of the Goldman Sachs Global Health Care Conference. My name is Graig Suvannavejh, I cover European and U.S. biopharma for the firm. I've got the great pleasure introducing Cytokinetics, welcome Robert Blum to our conference. Robert is the Chief Executive Officer. And we'll spend the next 40 minutes kind of getting to know Cytokinetics, and we'll obviously ask a few questions. But with that said, Robert, welcome. Thank you for joining us.
Robert I. Blum
Cytokinetics, Incorporated - CEO, President & Director
Thank you, Graig, very nice to be here. Thank you.
Questions & Answers
Graig Suvannavejh
Goldman Sachs Group Inc., Research Division - Executive Director & Senior Equity Research Analyst
Sure. Maybe before we go into kind of detailed questions about what's happening with the company right now, I
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot